The Latin America, Middle East and Africa Gene Synthesis Market would witness market growth of 21.1% CAGR during the forecast period (2021-2027).
An artificial gene is a human-made replacement of the cell-free protein synthesis of double-stranded DNA molecules. This technology is widely used in the biotechnology sector and crucial for synthetic biology. Also, it is a crucial tool that is used in numerous sectors of recombinant DNA technology including gene therapy, molecular engineering, developing vaccines, and heterologous gene expression.
Healthcare technology, connected devices, genomics, artificial intelligence, and big data analytics are the sectors that comprise a broad range of data and insights associated with health. This is a factor that allows the healthcare service providers to deliver diagnoses to the patients in a lesser interval of time as well as enable them to make well-informed decisions about the treatment of patients.
LAMEA would be a really profitable region for the gene synthesis market due to the growing number of studies in the field of synthetic biology and genes in the different countries of the region. South Africa is a country with a significant number of genetic disorders which can be cured with the help of gene synthesis. Also, the significant number of various key players of the pharmaceuticals existing in LAMEA such as Europharma, Mantecorp farmasa, Novartis, and Pfizer, makes LAMEA a significant producer and provider of gene synthesis outputs for rest of the LAMEA.
The Brazil market dominated the LAMEA Gene Synthesis Market by Country 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $87.1 million by 2027. The Argentina market is anticipated to grow a CAGR of 21.8% during (2021 - 2027). Additionally, The UAE market would exhibit a CAGR of 20.8% during (2021 - 2027).
Based on Method, the market is segmented into Solid-phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis. Based on Service Type, the market is segmented into Antibody DNA Synthesis, Viral DNA Synthesis and Others. Based on Application, the market is segmented into Gene & Cell Therapy Development, Vaccine Development, Disease Diagnosis and Others. Based on End User, the market is segmented into Academic & Government Research Institutes, Biotechnology & Pharmaceutical Companies and Contract Research Organizations. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Gene Synthesis Market is Predict to reach $5.2 Billion by 2027, at a CAGR of 17.9%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Genscript Biotech Corporation, Thermo Fisher Scientific, Inc., Brooks Automation, Inc., Boster Biological Technology, Twist Bioscience Corporation, Danaher Corporation, Biomatik Corporation, ProteoGenix, ProMab Biotechnologies, Inc., and OriGene Technologies, Inc.
By Method
By Service Type
By Application
By End User
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 